期刊文献+

碳酸酐酶Ⅳ与人类疾病 被引量:3

Carbonic Anhydrase Ⅳ and Human Diseases
原文传递
导出
摘要 碳酸酐酶4(carbonic anhydrase 4,CAIV)是12种人类相关碳酸酐酶中的一员,主要通过糖基磷脂酰基醇锚定在细胞质膜上。哺乳动物的多个器官有CAIV的表达。CAIV高效催化CO2的水化和HCO3–的脱水反应,在尿液酸化、肺泡换气等生理反应中起重要作用。CAIV基因表达的变化、结构稳定性的破坏和活性的改变等均与人类多种疾病的发生发展密切相关。CAIV还可以作为药物治疗靶点应用于疾病治疗。为此,该文就CAIV与人类相关疾病发生的病理生理机制作一综述。 Carbonic anhydrase 4(CAIV) is one of the 12 kinds of human-related carbonic anhydrases.It anchored in the cytoplasmic membranein mainly by glycosylphosphatidylinositol.The expression of CAIV has been identified in multiple organs of mammals.CAIV efficiently catalyzes the reaction of CO2 hydration and HCO3– dehydration,and plays an important role in many physiological response,such as acidification of urine,alveolar ventilation,etc.CAIV gene expression changes,structural instability and activity loses are closely related to the development of many human diseases.CAIV can also be applied as a drug target for treatment of diseases.To this end,this paper draws a summary for the association between CAIV and the pathophysiology of human diseases.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2014年第11期1560-1566,共7页 Chinese Journal of Cell Biology
关键词 碳酸酐酶4 疾病 发生机制 carbonic anhydrase IV human disease pathogenesis
  • 相关文献

参考文献54

  • 1Imtaiyaz Hassan M, Shajee B, Waheed A, Ahmad F, Sly WS. Structure, function and applications of carbonic anhydrase isozymes. Bioorg Med Chem 2013; 21(6): 1570-82.
  • 2Okuyama T, Sato S, Zhu XL, Waheed A, Sly WS. Human car- bonic anhydrase IV: cDNA cloning, sequence comparison, and expression in COS cell membranes. Proc Natl Acad Sci USA 1992; 89(4): 1315-9.
  • 3Waheed A, Okuyama T, Heyduk T, Sly WS. Carbonic anhydrase IV: Purification of a secretory form of the recombinant human enzyme and identification of the positions and importance of its disulfide bonds. Arch Biochem Biophys 1996; 333(2): 432-8.
  • 4Tamai S, Waheed A, Cody LB, Sly WS. Gly-Gln substitu- tion adjacent to His-64 in rodent carbonic anhydrase lVs largely explains their reduced activity. Proc Natl Acad Sci USA 1996; 93(24): 13647-52.
  • 5Sterling D, Alvarez B V, Casey J R. The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE 1 Cl/HCO3 exchanger binds carbonic anhydrase IV. J Biol Chem 2002; 277(28): 25239-46.
  • 6Alvarez BV, LoiseUe FB, Supuran CT, Schwartz G J, Casey JR. Direct extracellular interaction between carbonic anhydrase IV and the human NBC1 sodium/bicarbonate co-transporter. Bio- chemistry 2003; 42(42): 12321-9.
  • 7Stams T, Nair SK, Okuyama T, Waheed A, Sly WS, ChristiansonDW. Crystal structure of the secretory form of membrane-associ- ated human carbonic anhydrase IV at 2.8-A resolution. Proc Natl Acad Sci USA 1996; 93(24): 13589-94.
  • 8Monti SM, Supuran CT, de Simone G. Anticancer carbonic an- hydrase inhibitors: A patent review (2008-2013). Expert Opin Ther Pat 2013; 23(6): 737-49.
  • 9Schneider HP, Alt MD, Klier M, Spiess A, Andes FT, Waheed A, et al. GPI-anchored carbonic anhydrase IV displays both intra- and extracellular activity in cRNA-injected oocytes and in mouse neurons. Proc Natl Acad Sci USA 2013; 110(4): 1494-9.
  • 10Waheed A, Sly W S. Membrane associated carbonic anhydrase IV (CA IV): A personal and historical perspective. Subcell Bio- chem 2014; 75: 157-79.

二级参考文献159

  • 1王晓楠,孙联文,樊瑜波.微重力对骨组织细胞功能的影响[J].中华航空航天医学杂志,2012,23(2):151-156. 被引量:4
  • 2Oka M, Homma N, Taraseviciene-Stewart LG, Morris K, Kraskauskas D, Bums N,et al. Rho-kinase mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 2007; 100(6): 923-9.
  • 3Cool CD, Groshong SD, Oakey J,Voelkel NF. Pulmonary hypertension: Cellular and molecular mechanisms. Chest 2005; 128(6 Suppl): 565S-71S.
  • 4Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S): 13S-24S.
  • 5Connolly MJ, Aaronson PI. Key role of the RhoA/Rho kinase system in pulmonary hypertension. Pulm Pharmacol Ther 2011; 24(1): 1-14.
  • 6Loirand G, Guerin P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology. Circ Res 2006; 98(3): 322-4.
  • 7Nossaman BD,Kadowitz PJ. The Role of the RhoA/rho-kinasepathway in pulmonary hypertension. Curr Drug Discov Technol 2009; 6(1): 59-71.
  • 8Ming XF,Viswambharan H, Barandier C,RufFieux J, Kaibuchi K, Rusconi S, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 2002; 22(24): 8467-77.
  • 9Shi J, Wei L. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz) 2007; 55(2): 61-75.
  • 10Guilluy C, Eddahibi S, Agard C, Guignabert C, Izikki M,Tu L, et al. RhoA and Rho kinase activation in human pulmonary hypertension: Role of 5-HT signaling. Am J Respir Crit Care Med 2009; 179(12): 1151-8.

共引文献66

同被引文献48

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部